LAROSA JOSEPH J 1238303 Data last updated 2024-05-14 07:02:16 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-12 | 2023-12-08 | 2023-12-08 to 2023-12-11 | 4 | Larosa Joseph J | EVP GENERAL COUNSEL AND SECRET | dsp | 1521.0 | 4.82 | 0.14 | 843.92 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code F | 30036.0
|
107.13 (REGN) |
| 2023-12-12 | 2023-12-08 | 2023-12-08 | 4 | Larosa Joseph J | EVP GENERAL COUNSEL AND SECRET | acq | 2133.0 | 6.95 | 0.2 | 0.0 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code A | 30705.0 | 107.13 (REGN) |
| 2023-12-12 | 2023-12-08 | 4 | Larosa Joseph J | EVP GENERAL COUNSEL AND SECRET | holding | 3367.0 | 0 | 0.31 | 0.0 | 2022 Grat | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.13 (REGN) | ||
| 2023-12-12 | 2023-12-08 | 4 | Larosa Joseph J | EVP GENERAL COUNSEL AND SECRET | holding | 355.0 | 0 | 0.03 | 0.0 | By 401(K) Plan | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.13 (REGN) | ||
| 2024-01-04 | 2024-01-03 | 2024-01-03 | 4 | Larosa Joseph J | EVP GENERAL COUNSEL AND SECRET | acq | 34000.0 | 53.1 | 3.17 | 399.66 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code M | 64036.0 | 107.13 (REGN) |
| 2024-01-04 | 2024-01-03 | 2024-01-03 | 4 | Larosa Joseph J | EVP GENERAL COUNSEL AND SECRET | dsp | 24493.0 | 38.25 | 2.29 | 912.3 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code F | 39543.0 | 107.13 (REGN) |
| 2024-01-04 | 2024-01-03 | 4 | Larosa Joseph J | EVP GENERAL COUNSEL AND SECRET | holding | 3367.0 | 0 | 0.31 | 0.0 | 2022 Grat | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.13 (REGN) | ||
| 2024-01-04 | 2024-01-03 | 4 | Larosa Joseph J | EVP GENERAL COUNSEL AND SECRET | holding | 355.0 | 0 | 0.03 | 0.0 | By 401(K) Plan | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.13 (REGN) | ||
| 2024-02-09 | 2024-02-07 | 2024-02-07 | 4 | Larosa Joseph J | EVP GENERAL COUNSEL AND SECRET | dsp | 1000.0 | 2.53 | 0.09 | 950.0 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code S | 38543.0 | 107.94 (REGN) |
| 2024-02-09 | 2024-02-07 | 4 | Larosa Joseph J | EVP GENERAL COUNSEL AND SECRET | holding | 355.0 | 0 | 0.03 | 0.0 | By 401(K) Plan | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.94 (REGN) | ||
| 2024-02-09 | 2024-02-07 | 4 | Larosa Joseph J | EVP GENERAL COUNSEL AND SECRET | holding | 3367.0 | 0 | 0.31 | 0.0 | 2022 Grat | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.94 (REGN) | ||
| 2024-02-26 | 2024-02-22 | 2024-02-22 | 4 | Larosa Joseph J | EVP GENERAL COUNSEL AND SECRET | dsp | 1000.0 | 2.59 | 0.09 | 967.65 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code S | 37543.0 | 107.94 (REGN) |
| 2024-02-26 | 2024-02-22 | 4 | Larosa Joseph J | EVP GENERAL COUNSEL AND SECRET | holding | 355.0 | 0 | 0.03 | 0.0 | By 401(K) Plan | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.94 (REGN) | ||
| 2024-02-26 | 2024-02-22 | 4 | Larosa Joseph J | EVP GENERAL COUNSEL AND SECRET | holding | 3367.0 | 0 | 0.31 | 0.0 | 2022 Grat | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.94 (REGN) | ||
| 2024-02-28 | 2024-02-26 | 4 | Larosa Joseph J | EVP GENERAL COUNSEL AND SECRET | holding | 355.0 | 0 | 0.03 | 0.0 | By 401(K) Plan | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.94 (REGN) | ||
| 2024-02-28 | 2024-02-26 | 4 | Larosa Joseph J | EVP GENERAL COUNSEL AND SECRET | holding | 3367.0 | 0 | 0.31 | 0.0 | 2022 Grat | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.94 (REGN) | ||
| 2024-02-28 | 2024-02-26 | 2024-02-26 | 4 | Larosa Joseph J | EVP GENERAL COUNSEL AND SECRET | dsp | 1000.0 | 2.66 | 0.09 | 990.0 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code S | 36543.0 | 107.94 (REGN) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-12 | 2023-12-08 | 2023-12-08 | 4 | Larosa Joseph J | EVP GENERAL COUNSEL AND SECRET | acq | 7649.0 | 100.0 | 0.71 | 843.79 | Direct | Non Qualified Stock Option (Right To Buy) | REGENERON PHARMACEUTICALS, INC. | code A | 7649.0 | 107.13 (REGN) |
| 2024-01-04 | 2024-01-03 | 2024-01-03 | 4 | Larosa Joseph J | EVP GENERAL COUNSEL AND SECRET | dsp | 34000.0 | 100.0 | 3.17 | 399.66 | Direct | Non Qualified Stock Option (Right To Buy) | REGENERON PHARMACEUTICALS, INC. | code M | 0.0 | 107.13 (REGN) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)